John A. Orwin

John A. Orwin

Dir., President and Chief Executive Officer at Relypsa, Inc.

Are you John A. Orwin? Claim your profile
 
  • IDENTIFY corporate executives in John A. Orwin's network and community.
  • FOLLOW changes in John A. Orwin's employment and money-in-motion.
  • CONNECT with John A. Orwin through your network of contacts.

John A. Orwin's Executive Work History


Current
Dir., President and Chief Executive Officer, Relypsa, Inc.
Board Member, Seattle Genetics, Inc.
Board Member, Array BioPharma Inc.
Past
To view John A. Orwin's complete executive work history,
Age
52
 
 

John A. Orwin's Biography


John A. Orwin has served as a member of our board of directors since March 2017. Mr. Orwin currently serves as Chief Executive Officer of Relypsa, Inc, a biopharmaceutical company. From June 2013 through March 2017, Mr. Orwin also served as President of Relypsa and served on its board of directors from June 2013 until Relypsa's acquisition by the Galenica Group in September 2016. Prior to Relypsa, Mr. Orwin served as President and Chief Operating Officer of Affymax, Inc., a biotechnology company, from April 2010 to January 2011, and as Affymax's Chief Executive Officer and a member of the board of directors from February 2011 to May 2013. Fro ...

(Read More)

Source: Retrophin, Inc. on 04/28/2016

 

By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like John A. Orwin. More specifically, you'll be able to:

  • IDENTIFY corporate executives in John A. Orwin's network and community.
  • FOLLOW changes in John A. Orwin's employment and money-in-motion.
  • CONNECT with John A. Orwin through your network of conections.
 

Search for over 360,000 executive profiles.

/bio

Example: John A. Orwin

John A. Orwin's Connections (235)


Chief Operating Officer, Seattle Genetics, Inc.
Chairman of the Board, Chief Executive Officer and President, OncoMed Pharmaceuticals, Inc.
Chief Commercial Officer and Senior Vice President, Relypsa, Inc.
Dir., President, Chief Executive Officer and Acting Principal Financial Officer, Conatus Pharmaceuticals Inc.
Chief Medical Officer and Executive Vice President, Research and Development, Seattle Genetics, Inc.
Chief Financial Officer and Interim President, Nivalis Therapeutics, Inc.